R&D News | pharmaphorum

News

Study finds hundreds of overlooked cancer drug targets

Researchers from the Wellcome Sanger Institute and partners have carried out a comprehensive analysis of cancer cells, identifying 370 ‘priority’ targets that could be use

News

Alphabet spinout SandboxAQ buys Good Chemistry

Two years after spinning out of the Google parent Alphabet, quantum computing and artificial intelligence specialist SandboxAQ has bought one of its smaller rivals in a de

News

JPM: Precision Bio continues offload of CAR-T rights

Precision BioSciences has agreed to a second licensing deal for its ‘off-the-shelf’ CAR-T therapy azer-cel, as it switches focus to developing in vivo applications of its

News

Novo Nordisk Foundation puts $25m into AMR programme

The Novo Nordisk Foundation has come up with more funding to help battle the scourge of antimicrobial resistance (AMR), putting $25 million into a non-profit accelerator p

News

JPM on tenterhooks over Novartis-Cytokinetics merger rumour

With M&A news coming thick and fast on the first day of the JP Morgan Healthcare conference in San Francisco, attendees were left hanging as proceedings closed with no

News

JPM: GSK announces $1.4bn deal to buy asthma biotech Aiolos

GSK has taken another step towards rebuilding its respiratory pipeline with a $1.4 billion agreement to buy Aiolos Bio and its lead drug AIO-001 for asthma and other indic

Study finds hundreds of overlooked cancer drug targets

Alphabet spinout SandboxAQ buys Good Chemistry

JPM: Precision Bio continues offload of CAR-T rights

Novo Nordisk Foundation puts $25m into AMR programme

JPM on tenterhooks over Novartis-Cytokinetics merger rumour

JPM: GSK announces $1.4bn deal to buy asthma biotech Aiolos

FDA grants three priority vouchers to psychedelics

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks